Willingness to use and preferences for long‐acting injectable PrEP ...

Willingness to use and preferences for long-acting injectable PrEP ...

Willingness to use LAI PrEP was high among SGM people in the southern United States, although there were some important differences in willingness based on ...

Willingness to use LAI PrEP was high among SGM people in the southern United States, although there were some important differences in willingness based on ...

Willingness and preferences for long-acting injectable PrEP among ...

Results Among 2506 MSM respondents, most (75%) indicated a willingness to use LA-PrEP versus daily oral PrEP versus no PrEP. Respondents were averse to side ...

"Willingness and preferences for long-acting injectable PrEP among ...

Setting US national online sample. Results Among 2506 MSM respondents, most (75%) indicated a willingness to use LA-PrEP versus daily oral PrEP ...

Willingness to take long-acting injectable pre-exposure prophylaxis ...

Evidence on the willingness of men who have sex with men (MSM) with oral pre-exposure prophylaxis (PrEP) experience, especially those with ...

Exploring preferences and decision-making about long-acting ...

Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (i.e., LAI-PrEP) was approved by the U.S. FDA in 2021.

Willingness and Preferences for Long-Acting Injectable PrEP Among ...

64% <30 years old. 64% White / 9% Black / 19% Hispanic. 78% ≥some university education. 60% urban or suburban. ---. 13% current oral PrEP use. 15% past oral ...

Intention and preference to use long-acting injectable PrEP among ...

This study investigated the intention and preference to use LAI-PrEP among MSM in the Netherlands by employing a diffusion of innovation approach.

Awareness about and willingness to use long-acting injectable pre ...

Highlights · Long-acting injectable PrEP (LAI-PrEP) is currently being studied as an alternative form of oral PrEP for HIV prevention. · We examined the awareness ...

Willingness to use and preferences for long-acting injectable PrEP ...

In multivariable log-binomial regression models, PrEP stigma was independently associated with less [prevalence ratio (PR) = 0.7, 95% confidence ...

Preference for long-acting injectable for ART and PrEP among ...

Among those with HIV, 91.5% expressed a high preference for LAI-ART, with significantly higher preferences among participants with higher ...

Preferences for Long-Acting PrEP Products Among Women and Girls

Stated willingness to use a PrEP implant was strongly positively correlated with implant effectiveness (Fig. 2). For every 10% increase in ...

Systematic review of the values and preferences regarding the use ...

Two randomized trials have provided efficacy evidence for long-acting injectable cabotegravir (CAB-LA) as PrEP. In considering CAB-LA as an ...

Perspectives on long-acting formulations of pre-exposure ...

SI-PrEP, similar to those used for contraception, provides sufficient drug concentrations to prevent HIV for up to one year [18]. Pill-based ...

Intention and preference for long-acting injectable PrEP among ...

83% showed high/very-high interest of, and 63% showed high/very-high intention to use LAI-PrEP. Early-adopters of oral PrEP use did not show ...

Acceptability of and willingness to pay for long-acting injectable pre ...

We assessed acceptability of and willingness to pay (WTP) for LAI PrEP, and CAB-LA specifically, as part of a larger study on use, preferences, and WTP for ...

WILLINGNESS AND PREFERENCES FOR LONG-ACTING ...

WILLINGNESS AND PREFERENCES FOR LONG-ACTING INJECTABLE PREP AMONG US MEN WHO HAVE SEX WITH MEN ... We use cookies to enhance your website experience. Some ...

Familiarity with and preferences for oral and long-acting injectable ...

Those who reported condomless anal sex and those who thought they were good PrEP candidates were more willing to take PrEP. Long-term health and side effects ...

Preference for long-acting injectable PrEP versus daily oral PrEP or ...

Results Half of survey participants (53%) indicated that they would be willing to administer LAI-PrEP via gluteal injection in their pharmacy. Willingness was ...

Willingness to use long-acting injectable PrEP among HIV ... - PLOS

found that. 46% of gay and bisexual men preferred LAI-PrEP compared to oral PrEP [38,39]. Therefore, we suppose that Chinese MSM will also have ...